These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 627526)

  • 1. Biological and chemotherapeutic studies on three semisynthetic cephamycins.
    Uri JV; Actor P; Guarini JR; Phillips L; Pitkin D; Demarinis RM; Weisbach JA
    J Antibiot (Tokyo); 1978 Jan; 31(1):82-91. PubMed ID: 627526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin and cephamycins: microbiological studies.
    Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
    Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephamycin derivatives: comparison of the in vitro and in vivo antibacterial activities of SQ 14,359, CS-1170, and cefoxitin.
    Gadebusch HH; Schwind R; Lukaszow P; Whitney R; McRipley RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):1046-58. PubMed ID: 711611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
    Yoshida T; Matsuura S; Mayama M; Kameda Y; Kuwahara S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):302-12. PubMed ID: 6448572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
    Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
    Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer cephalosporins and cephamycins--a review.
    Norrby R
    Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo laboratory studies on three hydroxyiminophenylacetyl cephalosporins with particular reference to SK&F 80303, an unusually long-acting cephalosporin.
    Uri JV; Actor P; Zajac I; Pitkin DH; Phillips L; Guarini JR; Bartus HF; Polansky TJ; Dunn GL; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1979 Nov; 32(11):1161-7. PubMed ID: 118958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.
    Inouye S; Goi H; Watanabe T; Hara T; Miyauchi K; Yoshida T; Kazuno Y; Kadosawa H; Hirano F; Kawaharajo K
    Antimicrob Agents Chemother; 1984 Nov; 26(5):722-9. PubMed ID: 6440478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
    Wallick H; Hendlin D
    Antimicrob Agents Chemother; 1974 Jan; 5(1):25-32. PubMed ID: 4840447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.
    Neu HC
    Antimicrob Agents Chemother; 1974 Aug; 6(2):170-6. PubMed ID: 15828188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in-vitro activity of cefotetan (ICI 156834), a new cephamycin derivative, with that of cefoxitin.
    Chattopadhyay B; Teli JC
    J Antimicrob Chemother; 1982 Aug; 10(2):151-4. PubMed ID: 6956565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.